Table 3

 Baseline data for the 268 survivors seen

Baseline dataEtamsylatePlacebo
*Standard deviation in parentheses.
†In first four days.
PVH, Periventricular haemorrhage.
Singleton/multiple birth97 (73%)/36 (27%)97 (72%)/38 (28%)
Male/female50 (38%)/83 (62%)65 (48%)/70 (52%)
Birth weight (g)*1154 (210)1166 (217)
Gestational age (weeks)*29.5 (2.3)29.6 (2.4)
Apgar score (5 min) <718 (13.5%)24 (17.8%)
Caesarean section73 (55%)83 (61%0
Respiratory distress†80 (60%)88 (65%)
Artificial ventilation†89 (67%)96 (71%)
Acidosis pH <7.15†40 (30%)34 (25%)
Hypercapnoea (Paco2>60 mm Hg or >8.2 kPa)40 (30%)36 (27%)
Pneumothorax†4 (3%)5 (4%)
Grade 3 PVH11 (8%)13 (10%)
Grade 2 PVH16 (12%)20 (15%)
Grade 1 PVH15 (11%)10 (7%)
No PVH91 (68%)92 (68%)
Maternal smoking59 (44%)55 (41%)
Maternal age at birth (years)*27.8 (5.8)26.9 (6.0)
Centre
    Bath11 (8%)12 (9%)
    Blackburn21 (16%)25 (18%)
    Bristol (BMH & Southmead)40 (30%)40 (30%)
    Cardiff15 (11%)11 (8%)
    Liverpool46 (35%)47 (35%)
Social class
    13 (2%)7 (5%)
    222 (17%)15 (11%)
    365 (49%)61 (45%)
    414 (10%)6 (4%)
    53 (2%)1 (1%)
    Unemployed26 (20%)45 (34%)
Total133135